MD Conference Express ICAO 2012 - (Page 1)

Peer-Reviewed ABDOMINAL OBESITY Clinical Trial Highlights OFFICIAL PEER-REVIEWED HIGHLIGHTS FROM THE 3rd International Congress on Abdominal Obesity Translational Research Therapeutic Updates July 9-12, 2012 Quebec City, Canada Visceral Adiposity Related to Cardiometabolic Risk and Type 2 Diabetes Visceral adiposity is an important correlate of cardiometabolic risk, yet its association after the diagnosis of type 2 diabetes remains unclear [Smith JD et al. J Clin Endocrinol Metab 2012]. Jean-Pierre Després, PhD, Université Laval, Québec City, Québec, Canada, discussed the association between visceral adiposity, fatty liver, and cardiometabolic risk. See page 6. A Professional Courtesy of ALSO IN THIS ISSUE • The Challenges of Predicting Risk • Taking Action on Excess Visceral Fat • Links Between Sugar-Sweetened Beverages and Multiple Health Risks  http://www.myhealthywaist.org http://www.goodwingroupintl.com

Table of Contents for the Digital Edition of MD Conference Express ICAO 2012

MD Conference Express ICAO 2012
Contents
The Challenges of Predicting Risk: Diabetes and Cardiovascular Disease
Visceral Adiposity Related to Cardiometabolic Risk and Type 2 Diabetes
Taking Action on Excess Visceral Fat
Sugar-Sweetened Beverages Linked to Multiple Health Risks
Visceral Adipose Tissue and Cardiometabolic Risk
Mechanisms and Consequences of Ectopic Fat Accumulation
Beyond Weight Loss: Rethinking Treatment Strategies for Obesity

MD Conference Express ICAO 2012

https://www.nxtbook.com/nxtbooks/md_conference_express/icao2012
https://www.nxtbookmedia.com